BD Newsroom - News and media
WEB3 days ago · Connor Bates Named President of BD Medication Management Solutions. FRANKLIN LAKES, N.J. (Oct. 1, 2024) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Connor Bates has been named worldwide... Read More.
Press releases - BD Newsroom
WEB4 days ago · BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new data that highlights how its advanced artificial intelligence technology can help... Sep 18, 2024. BD Expands Capacity for Advanced Prefillable Syringes and Enhances Injection Experience for …
BD Completes Acquisition of Critical Care from Edwards Lifesciences
WEBSep 3, 2024 · BD Completes Acquisition of Critical Care from Edwards Lifesciences. Expands BD's portfolio of smart connected care solutions with leading monitoring technologies, including advanced AI-enabled clinical decision tools.
BD to Acquire Edwards Lifesciences' Critical Care Product Group …
WEBJun 3, 2024 · BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Edwards Lifesciences (NYSE: EW), today announced a definitive agreement under which BD will...
BD Reaches Agreement to Resolve Vast Majority of Hernia Litigation
WEB3 days ago · Settlement will not change BD's cash flow goals or capital allocation strategy. FRANKLIN LAKES, N.J., Oct. 2, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has reached an agreement to resolve the vast majority of its existing hernia litigation.
Edwards Lifesciences to Sell Critical Care to BD
WEBJun 3, 2024 · IRVINE, CA-- (BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX), in an all-cash transaction valued at $4.2 billion.
BD Reports First Quarter Fiscal 2024 Financial Results
WEBFeb 1, 2024 · Q1 revenue of $4.7 billion increased 2.6% as reported, 1.6% currency-neutral and 2.4% organic. Q1 GAAP and adjusted diluted EPS from continuing operations of $0.96 and $2.68, respectively. Company raises full-year adjusted EPS guidance and midpoint of organic revenue growth guidance.
BD Reaches Agreement to Resolve Vast Majority of Hernia Litigation
WEB3 days ago · BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has reached an agreement to resolve the vast majority of its existing hernia litigation.
Advancing the World of Health | BD
WEBNEWS. New Data Reveals BD's Artificial Intelligence Software Highly Effective in Detecting Indicators of Controlled Substance Diversion. BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new data that highlights how its advanced artificial intelligence technology can help... Learn More.
BD Advances "One-Stick Hospital Stay" Vision with Launch of Next ...
WEBNov 2, 2023 · The latest innovation in the BD Peripheral Line Draw Solution further drives the BD "One-Stick Hospital Stay" vision across each of its three pillars ― including (1) helping to reduce...